Sintx Technologies Inc.

3.04
-0.27 (-8.16%)
At close: Mar 03, 2025, 3:59 PM
3.23
6.25%
After-hours: Mar 03, 2025, 04:12 PM EST

Company Description

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States.

The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone.

The company was formerly known as Amedica Corporation.

Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Sintx Technologies Inc.
Sintx Technologies Inc. logo
Country United States
IPO Date Feb 13, 2014
Industry Medical - Devices
Sector Healthcare
Employees 43
CEO Eric K. Olson

Contact Details

Address:
1885 West 2100 South
Salt Lake City, Utah
United States
Website https://www.sintx.com

Stock Details

Ticker Symbol SINT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001269026
CUSIP Number 829392307
ISIN Number US8293926049
Employer ID 00-0000000
SIC Code 3841

Key Executives

Name Position
Eric K. Olson President, Chief Executive Officer & Director
Dr. Ryan Bock Ph.D. Chief Technology Officer
Ann Kutsch President of SINTX Technology Assessment & Transfer
Gina Moss Director of Operations
Gregg Richard Honigblum Chief Strategy Officer

Latest SEC Filings

Date Type Title
Feb 26, 2025 8-K Current Report
Feb 20, 2025 8-K Current Report
Feb 14, 2025 SCHEDULE 13G/A [Amend] Filing
Feb 14, 2025 SCHEDULE 13G/A [Amend] Filing
Dec 23, 2024 8-K Current Report
Dec 13, 2024 8-K Current Report
Nov 29, 2024 8-K Current Report
Nov 26, 2024 DEFA14A Filing
Nov 19, 2024 8-K Current Report
Nov 18, 2024 8-K Current Report